REFERENCES FOR:
"Breast Cancer Incidence on Long Island: Environmental Impact"
-
 A report by: Dr. Noelle Cutter (Molloy University) and Ben Honigsfeld

 

Akdag, M. Z., Dasdag, S., Canturk, F., & Karabulut, D. (2016). Can the antidiabetic drug metformin mitigate breast cancer through the alteration of environmental pollutant-induced androgen receptor activation in the breast tissue of diabetic women? Journal of Breast Cancer, 19(3), 312–316.

BNL Begins Pumping Water out of HFBR’s Spent-Fuel Pool; Year’s Events Prompt Close Looks at HFBR and Lab. (1998, January 2). Brookhaven Bulletin, 1–2.

Boice Jr, J. D., & Miller, R. W. (2012). Childhood and Adult Cancer After In Utero Exposure to Ionizing Radiation. Teratology, 59(4), 227-233.

Diamanti-Kandarakis, E., Bourguignon, J. P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., … & Zoeller, R. T. (2009). Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocrine Reviews, 30(4), 293–342.

Dismantling of the Shoreham Nuclear Plant Is Completed. (1994, October 13). The New York Times, 6.

Eastern District of New York | Northrop Grumman Agrees to Pay the United States $35 Million for Cleanup Costs at Bethpage Site Costs | United States Department of Justice. (2022, April 12). https://www.justice.gov/usao-edny/pr/northrop-grumman-agrees-pay-united-states-35-million-cleanup-costs-bethpage-site-costs

Engel, L. S., Hill, D. A., Hoppin, J. A., Lubin, J. H., Lynch, C. F., Pierce, J., ... & Alavanja, M. C. R. (2017). Pesticide Use and Breast Cancer Risk Among Farmers' Wives in the Agricultural Health Study. American Journal of Epidemiology, 150(7), 642-653.

Environmental Investigation And Cleanup Activities At The Former U.S. Navy And Northrop Grumman Bethpage Facility Sites—NYSDEC. (2024, May 10). https://dec.ny.gov/environmental-protection/site-cleanup/regional-remediation-project-information/region-1/environmental-investigation-cleanup-activities-bethpage-facility-sites

Gammon, M. D., Neugut, A. I., Santella, R. M., Teitelbaum, S. L., Britton, J. A., Terry, M. B., ... & Levin, B. (2002). The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Research and Treatment, 74(3), 235-254.

Gregoire, A. M., VoPham, T., Laden, F., Yarosh, R., O’Brien, K. M., Sandler, D. P., & White, A. J. (2022). Residential ultraviolet radiation and breast cancer risk in a large prospective cohort. Environment International, 159, 107028. https://doi.org/10.1016/j.envint.2021.107028

Grün, F., & Blumberg, B. (2006). Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology, 147(6), S50–S55.

Helm, J. S., & Rudel, R. A. (2020). Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Archives of Toxicology, 94(5), 1511–1549. https://doi.org/10.1007/s00204-020-02752-z

Hystad, P., Setton, E., Cervantes, A., Poplawski, K., Deschenes, S., Brauer, M., ... & Demers, P. A. (2013). Creating National Air Pollution Models for Population Exposure Assessment in Canada. Environmental Health Perspectives, 121(8), 1-7.

Kim, J., & Fortner, J. (n.d.). Project 4: Modular, Oxidation and Co-Contaminants. Yale Superfund Research Center, Yale School of Public Health. Retrieved May 15, 2024, from https://ysph.yale.edu/superfund-research-center/research/single-chemical-and-mixtures-studies/

New York State Department of Health. (2022). Health Consultation Groundwater Impacts NORTHROP GRUMMAN/NAVAL WEAPONS INDUSTRIAL RESERVE PLANT FACILITIES BETHPAGE, NASSAU COUNTY AND CALVERTON, SUFFOLK COUNTY, NEW YORK. https://www.health.ny.gov/environmental/investigations/northrop_grumman/docs/health_consultation.pdf

NYS Cancer Registry. (2023, May). Cancer Incidence and Mortality in New York State, 1976-2020. https://www.health.ny.gov/statistics/cancer/registry/

Pogribny, I. P. (2019). Environmental Exposures and Epigenetic Perturbations. In P. Boffetta & P. Hainaut (Eds.), Encyclopedia of Cancer (Third Edition) (pp. 574–584). Academic Press. https://doi.org/10.1016/B978-0-12-801238-3.65062-6

Safe, S. (2000). Endocrine disruptors and human health: Is there a problem? An update. Environmental Health Perspectives, 108(6), 487–493.

Shetty, S., Deepith, D., Harshitha, S., Sonkusare, S., Naik, P. B., Kumari N, S., & Madhyastha, H. (2023). Environmental pollutants and their effects on human health. Heliyon, 9(9), e19496. https://doi.org/10.1016/j.heliyon.2023.e19496

Soto, A. M., Rubin, B. S., & Sonnenschein, C. (2015). Interpreting Endocrine Disruption from an Integrative Biology Perspective. Endocrinology, 156(6), 2254-2264.

Superfund site: HOOKER CHEMICAL & PLASTICS CORP./RUCO POLYMER CORP. Site Profile. (n.d.). Cumulis.Epa.Gov. Retrieved May 15, 2024, from https://cumulis.epa.gov/supercpad/SiteProfiles/index.cfm?fuseaction=second.cleanup&id=0201477

Teitelbaum, S. L., Gammon, M. D., Britton, J. A., Neugut, A. I., Levin, B., & Stellman, S. D. (2007). Reported residential pesticide use and breast cancer risk on Long Island, New York. American Journal of Epidemiology, 165(6), 643–651. https://doi.org/10.1093/aje/kwk046

World Cancer Research Fund/American Institute for Cancer Research. (2018). Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018.

Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs Jr, D. R., Lee, D. H., … & vom Saal, F. S. (2012). Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocrine Reviews, 33(3), 378–455.

Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., … & Woodruff, T. J. (2012). Endocrine-disrupting chemicals and public health protection: A statement of principles from The Endocrine Society. Endocrinology, 153(9), 4097–4110.

 

 

IN THE NEWS...
Early Detection: The Risk of Being "Too Young for a Mammogram"
A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history? (click to read complete feature at the HEALTH RESOURCE DIGEST)